Additional information
| Therapeutic Segment | Anti-diabetic |
|---|---|
| Dosage Form | Tablets |
| Specialities | Diabetologist, Physician |
- Provides effective glycemic control in type 2 diabetes
- Glimepiride stimulates insulin secretion from the pancreas for rapid postprandial glucose reduction
- Metformin SR improves insulin sensitivity and reduces hepatic glucose production
- Bilayered formulation ensures both immediate and sustained blood sugar control
- Reduces risk of hyperglycemia-related complications when used with diet and exercise
GLIMEPIRIDE+METFORMIN belongs to a class of medicines called anti-diabetic drugs used in the treatment of type 2 diabetes, especially in patients whose blood sugar levels are not controlled by diet and exercise alone. Type 2 diabetes is a chronic (long-lasting) condition that affects the way our body processes glucose. People with type 2 diabetes either do not produce enough insulin, or the insulin produced is unable to perform its function in the body (insulin resistance).
GLIMEPIRIDE+METFORMIN is a combination of two antidiabetic drugs, namely: Glimepiride and Metformin. Glimepiride works by stimulating beta cells in the pancreas that produce insulin. Thus, insulin helps to remove sugar from the blood. Metformin works by reducing the sugar production by cells in the liver and delays sugar absorption from the intestines. Also, it increases the sensitivity of muscle cells to insulin, which enables these cells to remove sugar more effectively from the blood.
